Porton Pharma Solutions (300363.CH) - Not Easy to Get into the First Tier
This insight analyzed Porton about its past development, how it successfully made turnarounds, the future outlook, and concerns on deterioration of...
257 Views
Oral COVID-19 Antivirals and the Impact on China
This insight analyzed Pfizer's Paxlovid and Merck’s Molnupiravir after FDA EUA, the global market potential, the impact on China market and related...
376 Views
ECM Weekly (12th December 2021) - LG Energy, SenseTime (Delayed), Didi, Kanzhun & Full Truck Lock-Up
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
313 Views
Asymchem Labs A/H Trading - Moderate Demand and Upside
Asymchem Laboratories raised around US$1.05bn in its H-share listing in Hong Kong. In this note, we talk about the trading dynamics.
323 Views
ECM Weekly (5th December 2021) - Weibo, Asymchem, Grab, Yonghe, Gushengtang, Siam Makro, SF Intra
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
306 Views